Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 1997

View Archived Issues

Lipid peroxidation inhibitors from Gyogyszerkutato Intezet

New antibacterial agents described by Zeneca

Astra describes new topical anesthetics

Inhibitors of 5alpha-reductase prepared by Merck & Co.

P&U discloses inhibitors of enzyme involved in neurodegenerative diseases

Thrombin inhibitors revealed by Merck & Co.

Janssen prepares lubelozole N-oxides

BRL-49653: Profile of a potential new antidiabetic agent

BTS-67582 preclinical and clinical trials results

Agent for gastroparesis in diabetic patients

Studies reported on absorption of the insulin analogue HOE-901

New antidiabetic agent from Japan Tobacco

NN-304, a long-acting insulin analogue in preclinical testing

Skelid introduced in the U.S.

Introduction of Rescriptor in late June

Company profile: Trilex

Guilford's Parkinson's disease diagnostic safe and effective in phase IIb study

Micrologix Biotech enhancin restores activity of vancomycin

Synthelabo and Praecis collaborate on prostate cancer product

Peptidomimetic inhibitors of fungal NMT prepared by Searle

Encouraging interim data from Avicidin trial

Protein repair enzyme may be involved in seizures/neurodegenerative diseases

Chugai MSD to market OTC famotidine in Japan

Pfizer terminates E5 marketing agreement

Physostigmine improves working memory and alters neural activity in volunteers

Retinal protein reduces need for standard drugs in uveitis

Eclipse cleared by FDA to begin clinical trials of PTMR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...